Archives
-
Tariquidar (XR9576) in Viscosity-Driven Resistance
2026-09-11
Tariquidar (XR9576) provides a selective way to test whether mechanically induced P-glycoprotein activity is functionally responsible for chemoresistance. This workflow connects tumor-like fluid viscosity with efflux assays, transporter expression, and mechanobiology readouts for more informative drug resistance research.
-
JNK-IN-7 Workflow for Apoptosis and JNK Signaling
2026-09-11
JNK-IN-7 combines nanomolar activity across JNK1, JNK2, and JNK3 with a covalent mechanism suited to pathway-dissection experiments. This guide translates Candida krusei–induced bovine mammary epithelial cell apoptosis findings into practical inhibitor workflows, controls, and troubleshooting strategies.
-
Viperin–nsp8 Disruption of Coronavirus Replication
2026-09-10
A 2026 study identifies a nonenzymatic antiviral mechanism in which viperin binds coronavirus nsp8, interferes with replication-transcription complex assembly, and reduces RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work distinguishes this protein-interaction mechanism from ddhCTP-mediated chain termination and suggests a conserved coronavirus target for future antiviral drug development.
-
Palonosetron Hydrochloride Assay Strategy
2026-09-10
Palonosetron hydrochloride is more than a highly selective 5-HT3 receptor antagonist. This guide develops an evidence-based assay strategy linking receptor pharmacology with OCT2 and MATE1 renal transporter inhibition for translational cancer research.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-09
The reference study develops chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its data connect restored nuclear p21 expression with cell-cycle suppression, DNA-damage signaling, apoptosis, bladder-localized protein expression, and reduced tumor growth in an orthotopic mouse model.
-
Ibotenic Acid in Pain-Circuit Research Workflows
2026-09-09
Use Ibotenic acid as a controlled NMDA receptor agonist for region-level perturbation, excitotoxic lesion studies, and glutamatergic circuit validation. This workflow-focused guide shows how to connect focal chemical manipulation with behavioral phenotyping while avoiding the interpretive errors that arise when broad neuronal injury is mistaken for cell-type specificity.
-
Q-VD(OMe)-OPh in Apoptosis Research
2026-09-08
Q-VD(OMe)-OPh is a broad-spectrum pan-caspase inhibitor for controlled apoptosis modulation. Its reported activity against recombinant caspases and low reported cytotoxicity support applications in apoptosis assays, acute myeloid leukemia differentiation, and neuroprotection in ischemic stroke models.
-
NU7441 Workflows for DNA-PK Research
2026-09-07
NU7441 (KU-57788) gives researchers a selective way to interrogate DNA-PK-dependent repair, cell-cycle responses, and treatment sensitization. This practical guide connects assay design, dosing, controls, and troubleshooting for DNA repair research and oncology research.
-
Structural Tuning of CD38 CAR Binders
2026-09-07
Cheng et al. define how two CD38-targeting CAR binders engage distinct antigen surfaces and differentially affect CD38 enzymatic activity. The study links structural epitope recognition with affinity tuning, reduced CAR-T fratricide, and preserved antitumor cytotoxicity, providing a framework for designing more selective CD38-directed therapies.
-
Tetrandrine N1798: Reliable Cell Assay Design
2026-09-05
Learn how Tetrandrine (SKU N1798) can be incorporated into cell viability, proliferation, and ion channel workflows while controlling solubility, vehicle, and interpretation risks. This scenario-based guide connects product specifications with practical assay design and evidence-aware data analysis.
-
Liproxstatin-1 Workflow for Ferroptosis Research
2026-09-04
Liproxstatin-1 is a nanomolar ferroptosis inhibitor for separating lipid peroxidation-driven death from apoptosis, oxidative stress, and copper-associated cytotoxicity. This practical guide covers cell-based rescue assays, GPX4-deficient cell protection, renal injury workflows, assay controls, and troubleshooting.
-
Coumestrol, PMAIP1, and Ferroptosis in RA
2026-09-04
A 2026 study identifies a PMAIP1-dependent ferroptosis mechanism through which Coumestrol suppresses rheumatoid arthritis fibroblast-like synoviocyte proliferation and inflammatory signaling. The work connects TRIM3-mediated protein stability, mitochondrial stress, and iron accumulation, while providing a useful in vitro framework for evaluating this compound beyond its established estrogen receptor pharmacology.
-
Ionomycin calcium salt: Calcium Signaling Workflows
2026-09-03
Ionomycin calcium salt provides a practical way to raise intracellular Ca2+ and connect calcium dynamics with secretion, protein regulation, viability, and apoptosis assays. This workflow-focused guide shows how to build controlled calcium perturbation experiments while using the malignant pleural mesothelioma literature to improve assay stratification without overstating translational evidence.
-
BMS-345541 Hydrochloride in Cell-Fate Research
2026-09-03
BMS-345541 hydrochloride is an allosteric IKK inhibitor that can separate NF-κB transcriptional survival signals from RIPK1-driven cell death. This article presents a pathway-aware framework for inflammation research, T-ALL apoptosis studies, and mechanistically resolved assay design.
-
Podophyllotoxin Derivative 5p and MDR
2026-09-02
The reference study shows that podophyllotoxin derivative 5p combines catalytic topoisomerase IIα inhibition with suppression of microtubule polymerization, producing activity against several multidrug-resistant cancer models. Its effects connect target inhibition with G2/M arrest, apoptosis, pyroptosis, reduced drug-efflux protein expression, and impaired resistant-tumor growth in xenografts.